Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 22 matching records.
22 results — page 1 of 1
- Level DNarrative ReviewPubMed
The role of the mesenchymal stem cell therapy in bone regeneration of osteoporosis: clinical translation and limitations.
Narrative Review on Face & Skin, published in Int Immunopharmacol (2026) — summary generated from the PubMed abstract.
- 2026
Int Immunopharmacol - Level BClinical TrialPubMed
Heterogeneity of mesenchymal stem cells as a limiting factor in their clinical application to inflammatory bowel disease in dogs and cats.
Clinical Trial on Chronic Inflammation, Immune Modulation, published in Vet J (2024) — summary generated from the PubMed abstract.
- 2024
Vet J - Level DNarrative ReviewEurope PMC
Mesenchymal stem cells from different sources for sepsis treatment: prospects and limitations
Narrative Review on Chronic Inflammation, Immune Modulation, published in Braz J Med Biol Res (2024) — summary generated from the PubMed abstract.
- 2024
Braz J Med Biol Res2 citations - Level DNarrative ReviewEurope PMC
Methods and Limitations of Augmenting Mesenchymal Stem Cells for Therapeutic Applications
Narrative Review on Immune Modulation, published in Adv Wound Care (New Rochelle) (2023) — summary generated from the PubMed abstract.
- 2023
Adv Wound Care (New Rochelle)23 citations - Level DAnimal StudyPubMed
Mesenchymal stem cells limit vascular and epithelial damage and restore the impermeability of the urothelium in chronic radiation cystitis.
Animal Study on Systemic / IV, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cell Res Ther8 citations - Level DNarrative ReviewEurope PMC
Potential and Limitations of Induced Pluripotent Stem Cells-Derived Mesenchymal Stem Cells in Musculoskeletal Disorders Treatment
Narrative Review, published in Biomolecules (2023) — summary generated from the PubMed abstract.
- 2023
Biomolecules16 citations - Level DAnimal StudyPubMed
Dosing Limitation for Intra-Renal Arterial Infusion of Mesenchymal Stromal Cells.
Animal Study on Chronic Kidney Disease, Immune Modulation, published in Int J Mol Sci (2022) — summary generated from the PubMed abstract.
- 2022
Int J Mol Sci - Level BClinical TrialPubMed
Challenges and Limitations of Strategies to Promote Therapeutic Potential of Human Mesenchymal Stem Cells for Cell-Based Cardiac Repair.
Clinical Trial on Cardiovascular Disease, published in Korean Circ J (2021) — summary generated from the PubMed abstract.
- 2021
Korean Circ J23 citations - Level DAnimal StudyPubMed
Targeting microRNA-mediated gene repression limits adipogenic conversion of skeletal muscle mesenchymal stromal cells.
Animal Study, published in Cell Stem Cell (2021) — summary generated from the PubMed abstract.
- 2021
Cell Stem Cell - Level DNarrative ReviewPubMed
Hopes and Limits of Adipose-Derived Stem Cells (ADSCs) and Mesenchymal Stem Cells (MSCs) in Wound Healing.
Narrative Review on Chronic Wound, Skin Aging, published in Int J Mol Sci (2020) — summary generated from the PubMed abstract.
- 2020
Int J Mol Sci354 citations - Level DLaboratory StudyPubMed
Limited potential of AAV-mediated gene therapy in transducing human mesenchymal stem cells for bone repair applications.
Laboratory Study, published in Gene Ther (2020) — summary generated from the PubMed abstract.
- 2020
Gene Ther - Level BClinical TrialEurope PMC
Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy
Clinical Trial on Spinal Cord Injury, published in Int J Mol Sci (2019) — summary generated from the PubMed abstract.
- 2019
Int J Mol Sci290 citations - Level DNarrative ReviewEurope PMC
Dysfunction of Mesenchymal Stem Cells Isolated from Metabolic Syndrome and Type 2 Diabetic Patients as Result of Oxidative Stress and Autophagy may Limit Their Potential Therapeutic Use
Narrative Review on Type 2 Diabetes, Immune Modulation, published in Stem Cell Rev Rep (2018) — summary generated from the PubMed abstract.
- 2018
Stem Cell Rev Rep127 citations - Level DAnimal StudyPubMed
The Dietary Antioxidant Piceatannol Inhibits Adipogenesis of Human Adipose Mesenchymal Stem Cells and Limits Glucose Transport and Lipogenic Activities in Adipocytes.
Animal Study on Systemic / IV, published in Int J Mol Sci (2018) — summary generated from the PubMed abstract.
- 2018
Int J Mol Sci - Level DLaboratory StudyPubMed
Limited Endothelial Plasticity of Mesenchymal Stem Cells Revealed by Quantitative Phenotypic Comparisons to Representative Endothelial Cell Controls.
Laboratory Study, published in Stem Cells Transl Med (2018) — summary generated from the PubMed abstract.
- 2018
Stem Cells Transl Med13 citations - Level DAnimal StudyPubMed
A biological study establishing the endotoxin limit for osteoblast and adipocyte differentiation of human mesenchymal stem cells.
Animal Study, published in Regen Ther (2018) — summary generated from the PubMed abstract.
- 2018
Regen Ther8 citations - Level BClinical TrialEurope PMC
Regenerative potential of the cartilaginous tissue in mesenchymal stem cells: update, limitations, and challenges
Clinical Trial on Cartilage Damage, published in Rev Bras Ortop (2017) — summary generated from the PubMed abstract.
- 2017
Rev Bras Ortop11 citations - Level DAnimal StudyPubMed
A biological study establishing the endotoxin limit for in vitro proliferation of human mesenchymal stem cells.
Animal Study, published in Regen Ther (2017) — summary generated from the PubMed abstract.
- 2017
Regen Ther21 citations - Level CProspective StudyPubMed
Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Regulate the Phenotype of Smooth Muscle Cells to Limit Intimal Hyperplasia.
Prospective Study, published in Cardiovasc Drugs Ther (2016) — summary generated from the PubMed abstract.
- 2016
Cardiovasc Drugs Ther28 citations - Level DLaboratory StudyPubMed
Local transplantation of osteogenic pre-differentiated autologous adipose-derived mesenchymal stem cells may accelerate non-union fracture healing with limited pro-metastatic potency.
Laboratory Study, published in Int J Clin Exp Med (2015) — summary generated from the PubMed abstract.
- 2015
Int J Clin Exp Med9 citations - Level CProspective StudyPubMed
Human adipose-derived mesenchymal stem cells engineered to secrete IL-10 inhibit APC function and limit CNS autoimmunity.
Prospective Study on Neuroinflammation, Chronic Inflammation, Autoimmune Research, published in Brain Behav Immun (2013) — summary generated from the PubMed abstract.
- 2013
Brain Behav Immun47 citations - Level DNarrative ReviewPubMed
Commonly used mesenchymal stem cell markers and tracking labels: Limitations and challenges.
Narrative Review on Face & Skin, published in Histol Histopathol (2013) — summary generated from the PubMed abstract.
- 2013
Histol Histopathol
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406